SCM
NMTC icon

Sio Capital Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Sio Capital Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Sell
82,767
-2
-0% -$8 0.04% 54
2026
Q1 		$386K Sell
82,769
-107,238
-56% -$515K 0.06% 67
2025
Q4 		$864K Sell
190,007
-203,432
-52% -$927K 0.14% 57
2025
Q3 		$2.1M Sell
393,439
-193,838
-33% -$949K 0.53% 36
2025
Q2 		$2.39M Buy
+587,277
New +$2.17M 0.91% 30

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sio Capital Management's NMTC Position: Q2 2026 in Review

Sio Capital Management reduced its NeuroOne Medical Technologies (NMTC) stake by 0% in Q2 2026, selling an estimated $8 and leaving 82,767 shares worth $252K. The position accounts for 0.04% of the portfolio, ranked #54.

Sio Capital Management first reported a position in NMTC in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.39M in Q2 2025. 26 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Sio Capital Management held 82,767 shares of NeuroOne Medical Technologies worth $252K as of Q2 2026.
  • Sio Capital Management sold 2 NeuroOne Medical Technologies shares in Q2 2026, an estimated $8.
  • NeuroOne Medical Technologies made up 0.04% of Sio Capital Management's portfolio in Q2 2026, its #54 holding.
  • Sio Capital Management first reported a position in NeuroOne Medical Technologies in Q2 2025 and has held it in 5 quarters since.
  • Sio Capital Management's NeuroOne Medical Technologies position peaked at $2.39M in Q2 2025.
  • 26 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.